Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Zynerba Pharmaceuticals (ZYNE) Jumps: Stock Rises 15.1%

Zynerba Pharmaceuticals ZYNE was a big mover last session, as its shares rose over 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally reverses the downtrend for the company since Mar 14, as the stock is now down almost 37%.

Over the last 30 days, the company witnessed two positive and one negative estimate revision while the Zacks Consensus Estimate moved higher. This suggests more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Zynerba Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked med-generic stock is Amphastar Pharmaceuticals, Inc. AMPH with a Zacks Rank #1 (Strong Buy).

Is ZYNE going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AMPHASTAR PHARM (AMPH): Free Stock Analysis Report
 
ZYNERBA PHARMA (ZYNE): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research